Latest news
10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - StockStoryStockStory · Thu, 06 Aug 2026 22:16:40 GMTBioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations - StockStoryStockStory · Thu, 06 Aug 2026 20:46:27 GMTWhy Did Vontier (NYSE:VNT) Raise Full-Year EPS Outlook? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:14:00 GMTEPAM Systems Q2 revenue rises 4.5%, EPS up 26%, boosts full-year outlook - PluangPluang · Thu, 06 Aug 2026 14:57:45 GMTITT Reports 2026 Second Quarter Earnings Per Share (EPS) of $0.95, Adjusted EPS of $2.08; Raising Full Year Guidance on Revenue, Margin, EPS and Cash - Business WireBusiness Wire · Thu, 06 Aug 2026 11:30:00 GMTVontier Reports Strong Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business WireBusiness Wire · Thu, 06 Aug 2026 10:30:00 GMTAvient sales grow 5.8% to $917M; $100M-$150M debt repayment expected - Stock TitanStock Titan · Thu, 06 Aug 2026 10:13:00 GMTHorace Mann Q2 2026 Earnings: P&C Underwriting Supports Higher Core EPS Guidance - TradingKeyTradingKey · Wed, 05 Aug 2026 22:12:11 GMT